Source: MarketScreener

Camargo: FDA Designations for Rare Disease Products, Part 4: Humanitarian Use Device

(marketscreener.com) The Camargo Blog has published a four-part blog series highlighting those designation programs available specifically for products with rare disease indications. This final installment will explain the criteria, timeline, and benefits of Humanitarian Use Device designation. The HUD designation program is...https://www.marketscreener.com/news/latest/FDA-Designations-for-Rare-Disease-Products-Part-4-Humanitarian-Use-Device--33307379/?utm_medium=RSS&utm_content=20210520

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Daniel S. Duffy's photo - CEO of Camargo

CEO

Daniel S. Duffy

CEO Approval Rating

90/100

Read more